{"url_path":"/sec/cort/8-k/2026-06-17/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1088856/0001193125-26-274258-index.html","accession_number":"0001193125-26-274258","cik":"0001088856","ticker":"CORT","issuer_name":"CORCEPT THERAPEUTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1088856/0001193125-26-274258-index.html","primary_entity_key":"0001088856","primary_entity_name":"CORCEPT THERAPEUTICS INC"},"word_count":89,"has_tables":true,"body_markdown":"Item 9.01.\n\nFinancial Statements and Exhibits\n\n(d) Exhibits\n\n \n\nExhibits\nNo.\n\n  \n\nDescription\n\n 99.1\n  \n[Press Release of Corcept Therapeutics Incorporated, June 17, 2026.](d159941dex991.htm)\n\n104.1\n  \nCover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.\n\n \n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nCORCEPT THERAPEUTICS INCORPORATED\n\nDate: June 17, 2026\n \n\n \nBy:\n \n\n/s/ Atabak Mokari\n\n \n\n \nName:\n \nAtabak Mokari\n\n \n\n \nTitle:\n \nChief Financial Officer"}